Israeli Startup Raises $16 Million for Degenerative Disc Disease Treatment Discure Technologies, an Israeli startup, completed a $16 million round to advance its treatment for degenerative disc disease (DDD). The Series A round was led by BOLD Capital Partners, Supernova Invest, and Sanara Capital, with participation from U.S. hospital networks, orthopaedic surgeons, and MedTech investors. As the startup CEO Yuval Mandelbaum says, this investment will accelerate its growth, allowing it to make key hires and fully fund the First-in-Human clinical study in Canada and Italy. DDD accounts for 35% of all lower back pain. Whereas current treatments for DDD include opioids, injections and invasive surgery, Discure offers a disease-modifying solution. The funds will advance an implantable bioelectronic device designed to treat and reverse DDD by restoring fluids and nutrients to the affected discs. Source: https://lnkd.in/df7Uvrnd Photo: Yuval Mandelbaum
